Us Congress 2025-2026 Regular Session

Us Congress House Bill HB1463

Introduced
2/21/25  

Caption

To prohibit the use of Federal funds to implement, administer, or enforce a final rule of the Food and Drug Administration relating to "Medical Devices; Laboratory Developed Tests", and for other purposes.

Congress_id

119-HR-1463

Policy_area

Health

Introduced_date

2025-02-21

Companion Bills

No companion bills found.

Previously Filed As

US HJR145

Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Food and Drug Administration relating to "Medical Devices; Laboratory Developed Tests".

US SB4072

A bill to prohibit the use of funds to implement, administer, or enforce certain rules of the Environmental Protection Agency.

US HB10536

To amend title 38, United States Code, to establish a mission of the Veterans Health Administration to innovate, and for other purposes.

US SB5600

A bill to authorize programs for the National Aeronautics and Space Administration for fiscal year 2025, and for other purposes.

US SJR82

A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Food and Drug Administration relating to "Medical Devices; Laboratory Developed Tests".

US HB878

To direct the Administrator of the Federal Aviation Administration to appoint an Associate Administrator for Aviation Safety Technology, and for other purposes.

US HB3958

To direct the Administrator of the Federal Aviation Administration to publish guidance and implementation procedures for unmanned aircraft systems with respect to environmental reviews, and for other purposes.

US HB10524

To amend the Help America Vote Act of 2002 to prohibit the use of Federal funds for the administration of elections for Federal, State, or local office in States which do not have in effect laws to permit units of local government to hold elections for local office in odd-numbered years, and for other purposes.

US HB5850

To nullify modifications made by the Food and Drug Administration on January 3, 2023, to the risk evaluation and mitigation strategy under section 505-1 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 355-1) for mifepristone, and for other purposes.

US HB7827

To amend the Federal Food, Drug, and Cosmetic Act to encourage the development of vaccines to prevent, treat, or mitigate opioid, cocaine, methamphetamine, or alcohol use disorder, to establish an x-prize for the development of such a vaccine, and for other purposes.

Similar Bills

No similar bills found.